4.7 Article

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4

期刊

FASEB JOURNAL
卷 31, 期 7, 页码 3084-3097

出版社

FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.201700013R

关键词

CXCR4; signal transduction; synergism; allosteric receptor modulation

资金

  1. Medical Research Council [MR/L018284/1]
  2. Spanish Ministry of Economy and Competitiveness [SAF-2014-53416-R]
  3. Networks for Cooperative Research in Health Program (RETICS) [RD 12/0009/009 RIER]
  4. ComFuturo Program from Spanish Research Council General Foundation
  5. Swiss National Science Foundation [SNF 31003A_169936, SNF3100A0-143718/1]
  6. Agence Nationale de la Recherche [ANR-NT05-4-41968-Chemoglycan]
  7. Grenoble Instruct Centre (CNRS-CEA-UJF-EMBL) [UMS 3518]
  8. French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-02]
  9. Grenoble Alliance for Structural Biology Funding (GRAL) [ANR-10-LABX-49-01]
  10. Cardiff University Infection and Immunity Institutional Ph.D. Scholarship
  11. Royal Society Wolfson Research Merit Award
  12. Medical Research Council [MR/L018284/1] Funding Source: researchfish
  13. MRC [MR/L018284/1] Funding Source: UKRI

向作者/读者索取更多资源

The chemokine receptor, CXC chemokine receptor 4 (CXCR4), is selective for CXC chemokine ligand 12 (CXCL12), is broadly expressed in blood and tissue cells, and is essential during embryogenesis and hematopoiesis. CXCL14 is a homeostatic chemokine with unknown receptor selectivity and preferential expression in peripheral tissues. Here, we demonstrate that CXCL14 synergized with CXCL12 in the induction of chemokine responses in primary human lymphoid cells and cell lines that express CXCR4. Combining subactive concentrations of CXCL12 with 100-300 nM CXCL14 resulted in chemotaxis responses that exceeded maximal responses that were obtained with CXCL12 alone. CXCL14 did not activate CXCR4-expressing cells (i.e., failed to trigger chemotaxis and Ca2+ mobilization, as well as signaling via ERK1/2 and the small GTPase Rac1); however, CXCL14 bound to CXCR4 with high affinity, induced redistribution of cell-surface CXCR4, and enhanced HIV-1 infection by >3-fold. We postulate that CXCL14 is a positive allosteric modulator of CXCR4 that enhances the potency of CXCR4 ligands. Our findings provide new insights that will inform the development of novel therapeutics that target CXCR4 in a range of diseases, including cancer, autoimmunity, and HIV. Collins, P. J., McCully, M. L., Martinez-Mufioz, L., Santiago, C., Wheeldon, J., Caucheteux, S., Thelen, S., Cecchinato, V., Laufer, J. M., Purvanov, V., Monneau, Y. R., Lortat-Jacob, H., Legler, D. F., Uguccioni, M., Thelen, M., Piguet, V., Mellado, M., Moser, B. Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据